Patent Term Extension Application for DUVYZAT (givinostat), Patent No. 9,421,184 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2024-E-3861

Patent Term Extension Application for DUVYZAT (givinostat), Patent No. 9,421,184

Documents

Comments

Description

OPEN

Comment Period OpensAug 19, 2024

Type	Title	Posted	Comments	Status
Other	Letter from U.S Patent and Trademark Office to FDA CDER	Mar 25, 2026	--

CDER

Patent Term Extension Application

The Firm of Hueschen and Sage PLLC

Italfarmaco SPA

DUVYZAT (givinostat)

Patent No. 9,421,184

OPEN